Anti-Inflammatory Effects and Photo- and Neuro-Protective Properties of BIO203, a New Amide Conjugate of Norbixin, in Development for the Treatment of Age-Related Macular Degeneration (AMD)
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24065296 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Valérie Fontaine und 14 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 Rue Moreau, 75012 Paris, France. Hauptthemen laut MEDLINE: Macular Degeneration, Retinal Degeneration. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institut de la Vision, Biophytis, Programme Investissements d’Avenir IHU FOReSIGHT.
Abstract (Originalsprache)
9′-cis-norbixin (norbixin/BIO201) protects RPE cells against phototoxicity induced by blue light and N-retinylidene-N-retinylethanolamine (A2E) in vitro and preserves visual functions in animal models of age-related macular degeneration (AMD) in vivo. The purpose of this study was to examine the mode of action and the in vitro and in vivo effects of BIO203, a novel norbixin amide conjugate. Compared to norbixin, BIO203 displays improved stability at all temperatures tested for up to 18 months. In vitro, BIO203 and norbixin share a similar mode of action involving the inhibition of PPARs, NF-κB, and AP-1 transactivations. The two compounds also reduce IL-6, IL-8, and VEGF expression induced by A2E. In vivo, ocular maximal concentration and BIO203 plasma exposure are increased compared to those of norbixin. Moreover, BIO203 administered systemically protects visual functions and retinal structure in albino rats subjected to blue-light illumination and in the retinal degeneration model of Abca4−/− Rdh8−/− double knock-out mice following 6 months of oral complementation. In conclusion, we report here that BIO203 and norbixin share similar modes of action and protective effects in vitro and in vivo. BIO203, with its improved pharmacokinetic and stability properties, could be developed for the treatment of retinal degenerative diseases such as AMD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 Rue Moreau, 75012 Paris, France.
- Biophytis, Sorbonne Université, BC9, 4 Place Jussieu, 75005 Paris, France.
- Fondation Ophtalmologique Rothschild, 29 rue Manin, 75019 Paris, France.
- Department of Ophthalmology, School of Medicine, The University of Pittsburgh, Pittsburgh, PA 15213, USA.
ORCID-Profile: Serge Camelo
Förderung
- Institut de la Vision
- Biophytis
- Programme Investissements d’Avenir IHU FOReSIGHT
Zitieren
APA
Fontaine, V., Balducci, C., Dinan, L., Monteiro, E., Boumedine, T., Fournié, M., Nguyen, V., Guibout, L., Clatot, J., Latil, M., Veillet, S., Sahel, J. A., Lafont, R., Dilda, P. J., & Camelo, S. (2023). Anti-Inflammatory Effects and Photo- and Neuro-Protective Properties of BIO203, a New Amide Conjugate of Norbixin, in Development for the Treatment of Age-Related Macular Degeneration (AMD). International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065296
Vancouver
Fontaine V, Balducci C, Dinan L, Monteiro E, Boumedine T, Fournié M, et al. Anti-Inflammatory Effects and Photo- and Neuro-Protective Properties of BIO203, a New Amide Conjugate of Norbixin, in Development for the Treatment of Age-Related Macular Degeneration (AMD). International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065296
BibTeX
@article{Fontaine2023,
author = {Fontaine, Valérie and Balducci, Christine and Dinan, Laurence and Monteiro, Elodie and Boumedine, Thinhinane and Fournié, Mylène and Nguyen, Vincent and Guibout, Louis and Clatot, Justine and Latil, Mathilde and Veillet, Stanislas and Sahel, José-Alain and Lafont, René and Dilda, Pierre J and Camelo, Serge},
title = {Anti-Inflammatory Effects and Photo- and Neuro-Protective Properties of BIO203, a New Amide Conjugate of Norbixin, in Development for the Treatment of Age-Related Macular Degeneration (AMD)},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24065296}
}
EUVIMED